[ad_1]
The pharmaceutical company AstraZeneca with the University of Oxford in England, the coronavirus
(Covid-19) announced that they will produce a common vaccine against. Clinical experiments with patients
It is announced that the vaccine, which is said to be continuing, will be ready from June.
Oxford University, one of the prestigious universities in England, today
Currently under trial with British pharmaceutical company AstraZeneca
that the candidate for the coronavirus vaccine has reached an agreement to prepare it for use
He explained. The university made a written statement that clinical trials of the vaccine
and if it proves to be completely effective against the coronavirus, immediately to the production stage
stressed that it would be approved.
THE PURPOSE OF PROFIT WILL NOT INCREASE
As part of this partnership between AstraZeneca and the University of Oxford, the vaccine
The candidate will be accessible worldwide if successful. The vaccine is low and medium.
We will work with international partners to quickly distribute to income countries.
Both parties to the agreement are not for profit, only production and distribution.
reported that they had a budget for.
BE MARKET IN JUNE
Oxford University Professor of Medicine Sir John Bell, “Our partnership with AstraZeneca
It will be a great force in the fight against the epidemic in the coming years. An approved cash
When we have a vaccine, we will be in a strong state against the coronavirus. ”
Clinical trial results expected to be clear in June, positive
If obtained, production will start immediately.
You can rate this news 0 0
[ad_2]
